Filtering
- 5-Fluoruracil
- 5-Fu, oxaliplatin , leucovorin
- 5-HT3 antagonist
- 5-Hydroxytryptophan
- 5-Hydroxytryptophan 100 MG
- 5-aminolevulinic acid
- 5-aminosalicylic acid
- 5-azacitidine
- 5-azacytidine
- 5-day Temozolomide
- 5-fluoro-uracil
- 5-fluorouracil
- 5-fluorouracil (5-FU)
- 5-fluorouracil-based chemotherapy
- 5-fluoruracil
- 5-fu
- 5-mg Desloratadine
- 50 mcg salmeterol HFA MDI
- 50 mg Proellex
- 50 mg etanercept
- 50 mg of KX2-391 Ointment 1%
- 50 mg/mL Virazole
- 500 mg CK-2017357
- 500 mg metformin
- 552-02
- 5ARI
- 5ARI + AB
- 5FU
- 5Fluorouracil
- 5HTP
- 5fluorouracil
- 5mg Serlopitant Tablets
- 6 Mercaptopurine
- 6 cycles chemotherapy
- 6 months DAPT
- 6 months treatment with a single antiplatelet agent
- 6% hydroxyethyl starch 130/0.4
- 6,8-Bis(benzylthio)octanoic Acid
- 6,8-bis(benzylthio)octanoic acid
- 6-Mercaptopurine
- 6-Thioguanine
- 6-[18F]Fluorodopamine
- 6-mercaptopurine
- 6-thioguanine
- 60 mg dexlansoprazole capsules manufactured at TOB
- 60 mg dexlansoprazole capsules manufactured at TPC
- 60% Oxygen
- 600 mg Amoxicillin/42.9 mg Clavulanate Postassium /5 mL
- 600 mg Ceftaroline fosamil
- 601 1.25mg
- 609A
- 64Cu-ATSM
- 64Cu-DOTA-ECL1i
- 64Cu-FBP8
- 64Cu-SAR-BBN
- 64Cu-SAR-bisPSMA
- 64Cu-SARTATE
- 68-Ga PSMA11
- 68Ga PSMA-11 injection
- 68Ga-BBN-IRDye800CW
- 68Ga-BNOTA-PRGD2
- 68Ga-DOTA-FAPI
- 68Ga-DOTATATE
- 68Ga-DOTATATE PET/CT
- 68Ga-DOTATOC PET/CT
- 68Ga-Dotatate
- 68Ga-FAP-2286
- 68Ga-FAP-CHX
- 68Ga-FAP-RGD
- 68Ga-FAPI
- 68Ga-FAPI-04
- 68Ga-FAPi-46
- 68Ga-HBED-CC-PSMA
- 68Ga-HTK03149
- 68Ga-NEB
- 68Ga-NODAGA-E[c(RGDyK)]2
- 68Ga-NOTA-AE105
- 68Ga-NOTA-BBN-RGD
- 68Ga-NOTA-RM26
- 68Ga-NOTA-exendin-4
- 68Ga-NY104
- 68Ga-P16-093
- 68Ga-PSMA
- 68Ga-PSMA-11
- 68Ga-PSMA-617 PET/CT
- 68Ga-PSMA-HBED-CC
- 68Ga-Pentixafor
- 68Ga-RGD
- 68Ga-RM2
- 68Ga-RM2 PET/CT
- 68GaNOTA-Anti-HER2 VHH1
- 68GaNOTA-Anti-MMR-VHH2
- 6MW3211
- 6R-BH4
- 7% Hypertonic Saline (HS)
- 7-hydroxystaurosporine
- 7-hydroxystaurosporine (UCN-01)
- 70% ethanol
- 70% glycolic acid
- 70% isopropyl alcohol
- 700 µg Dexamethasone
- 75 mg linzagolix tablet
- 8% NVN1000 Topical Gel
- 8-Chloroadenosine
- 8.0% Arginine Dentifrice
- 80 mg ixekizumab
- 81mg aspirin
- 850 mg metformin
- 851B
- 852A
- 88% sucrose po solution
- ⁸⁹Zr-Df-IAB22M2C
- 89Zr-Girentuximab
- 89Zr-J591
- 89Zr-Pembrolizumab
- 89Zr-TLX250 PET/CT
- 89Zr-bevacizumab
- 8IU intranasal oxytocin
- 9-ING-41
- 9-NC in aerosol reservoir
- 90 mcg Reference Product
- 90 mcg Test Product
- 90Y Ibritumomab tiuxetan
- 90Y Zevalin
- 90Y-epratuzumab tetraxetan
- 90Y-hPAM4
- 90Y-ibritumomab tiuxetan (Zevalin)
- 91-day Levonorgestrel Oral Contraceptive
- 98% dehydrated alcohol
- 99Tc-MDP
- 99mTc-3PRGD2
- 99mTc-DARPinG3
- 99mTc-MIP-1404
- 99mTc-PYP
- 9MW0813
- 9MW2821
- Β-elemene
- "Kallunk oxide (Immunotherapy) "
- 'TOPROL-XL®' ER Tablets 200 mg
- [11C] JNJ-42491293
- [11C] JNJ-42491293 + JNJ-40411813
- [11C]-PIB
- [11C]-Pittsburgh Compound B ([11C]PiB)
- [11C]Acetate
- [11C]MK-3168
- [11C]NNC-112
- [11C]PBR28
- [11C]PiB and 18F-labeled DPA-714 PET scan
- [11C]UCB-J radiotracer
- [123I]β-CIT
- [14C] BIIB122 ([14C] DNL151)
- [14C] Selpercatinib
- [14C]-NV-5138
- [14C]-benzo[a]pyrene
- [14C]PCO371
- [177Lu]Lu-DOTA-TATE
- [177Lu]Lu-PSMA-617
- [177Lu]Ludotadipep
- [18F] Flutemetamol
- [18F] PBR111
- [18F](+/-)NOS
- [18F]-FTC-146
- [18F]-PI2620
- [18F]3F-PHPG
- [18F]4F-MHPG
- [18F]APN-1607
- [18F]AV-1451
- [18F]AV-45 PET amyloid binding imaging
- [18F]CTT1057
- [18F]DPA-714
- [18F]F-Ara-G
- [18F]F-AraG
- [18F]F-AraG (2'-deoxy-2'-fluoro-9-β-D-arabinofuranosylguanine)
- [18F]F-AraG PET Scan, baseline + post anti-PD-1 therapy.
- [18F]F13640
- [18F]FDG
- [18F]FP-R01-MG-F2
- [18F]FSPG
- [18F]FTC-146
- [18F]Florbetaben
- [18F]Florbetapir
- [18F]FluorThanatrace
- [18F]FluorThanatrace ([18F]FTT)
- [18F]Fluoroestradiol (FES) PET/CT
- [18F]Flutemetamol
- [18F]GTP1
- [18F]ISO-1
- [18F]MK-3328
- [18F]MNI-1054
- [18F]MNI-958
- [18F]MNI-968
- [18F]NAV4694
- [18F]NOS
- [18F]PI-2620
- [18F]PSMA-1007
- [18F]RO6958948
- [18F]THK-5351
- [18F]fluoro-2-deoxy-D-glucose (FDG)
- [68Ga]CBP8
- [68Ga]Ga-DOTA-TATE